Nativ Segev
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Nativ Segev
Non-Executive Director / Argent BioPharma
Nativ Segev is a co-founder of MGC Pharmaceuticals and its managing director. Mr Segev was chief executive of Israel’s second largest licensed medical cannabis company, Cann Pharmaceuticals, known as Better Cannabis and led it from startup through to a large private equity investment. He was also leading the medical cannabis regulation in Israel and the Czech Republic, alongside with developing new medical treatments and spearheading the discovery of new strains.
Lists and Charts
Total Shareholder Return as at 29/11/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 681st | 8I Holdings | 11% | -33% |
| 825th | Norwood Systems | 0% | 6% |
| 1204th | Skin Elements | -27% | -17% |
| 1569th | Argent BioPharma | -56% | 52% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 151st |  | 8I Holdings | $1.8m |
| 152nd |  | Norwood Systems | $1.7m |
| 153rd | | Argent BioPharma | $1.7m |
| 154th | | AusCann Group Holdings | $1.7m |
| 155th | | Skin Elements | $1.6m |
198 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, Argent BioPharma | 11 Jul 2024 |
| NEWS: Tagged in Board Moves May 31 to June 2, 2023 | 07 Jun 2023 |
| NEW ROLE: Managing Director, Argent BioPharma | 01 Sep 2020 |
| REMUNERATION UPDATE: Co-Founder, Executive Director & Head of Business Strategy since 2018, Argent BioPharma | 24 Aug 2020 |
| REMUNERATION UPDATE: Co-Founder, Executive Director & Head of Business Strategy since 2018, Argent BioPharma | 30 Jun 2020 |
